The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis.

ABSTRACT: Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID-19 patients, we conducted a systematic review and random-effects meta-analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37-54%, I²  = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37-57%, I²

SUBMITTER: Deng J 

PROVIDER: S-EPMC7675607 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature